i have no conflicts of interest to disclose
play

I have no conflicts of interest to disclose. 2 1 10/8/2018 it will - PDF document

10/8/2018 Simultaneous Heart Liver Transplant for the Treatment of Decompensated Fontan Patients Seth Hollander, MD Clinical Associate Professor, Pediatrics (Cardiology) Medical Director, Cardiac Transplantation I have no conflicts of interest


  1. 10/8/2018 Simultaneous Heart ‐ Liver Transplant for the Treatment of Decompensated Fontan Patients Seth Hollander, MD Clinical Associate Professor, Pediatrics (Cardiology) Medical Director, Cardiac Transplantation I have no conflicts of interest to disclose. 2 1

  2. 10/8/2018 …it will 4 2

  3. 10/8/2018 5 The Results of our “Success” 90% repaired CHD will survive into adulthood Mechanisms heart failure are different than for non CHD adults. Medical therapy often fails…Increase in referrals for transplantation 3.3% of adult heart transplants (40% increase over previous decades) 6 3

  4. 10/8/2018 Hypoplastic Left Heart Syndrome 7 Overview What is the Fontan Operation? Why does the liver “fail” in patients with Fontan circulation? Heart ‐ Liver Transplant Surgery Outcomes Immunologic Tolerance Ethics 8 4

  5. 10/8/2018 The Fontan Operation for HLHS 9 Fontan Operation Now standard of care for single ventricle disease. Early mortality is low. Survivors entering 20’s and 30’s. Not a long ‐ term solution. 10 5

  6. 10/8/2018 History Historically considered a contraindication to heart transplant secondary to concerns regarding bleeding, infection, varices. Liver failure in the setting of heart disease is increasing owing to improved long ‐ term survival in patients with single ventricle disease. Historical Contraindications = Current Indications 11 Decreased Cardiac Output High Central Venous Pressure 12 6

  7. 10/8/2018 13 Ghaferi A, 2004 Rychik, 2013. 14 7

  8. 10/8/2018 15 Indications 16 8

  9. 10/8/2018 Heart ‐ Liver Transplantation 17 Multi ‐ Organ Transplantation 18 9

  10. 10/8/2018 19 419 Heart Transplants since 1977 7 Heart ‐ Liver Transplants Multi ‐ Disciplinary Team 20 10

  11. 10/8/2018 Our First 7 Cases 7 Patients (5 Girls, 2 Boys) Ages 12 ‐ 19 6 Single Ventricles with FALD, 2 with PLE One TOF (2 ventricle) with primary liver disease 21 Heart ‐ Liver Transplant Planning Close collaboration between heart and liver teams Standardized multidisciplinary work ‐ up. Ultrasound, CT, MRI Cardiac Catheterization/Hepatic Vein Wedge Pressure Gradient Consider liver biopsy (during cath) 22 11

  12. 10/8/2018 Elastography 23 24 12

  13. 10/8/2018 Surgical Technique • Historically, the heart went in first, followed by the liver. • Simultaneous implantation • En bloc technique, where the heart and the liver are not separated. 25 26 13

  14. 10/8/2018 The Fontan Syndrome 27 Waitlist time: 131 Days (50-622) En bloc technique CPB: 3.58 Hours (2.97- 4.15) Donor Ischemic Time: 4.13 Hours (3.78-6.6) Total OR Time: (13-18.65) 70 60 50 40 POST CPB 30 ICU (48 Hrs) 20 10 0 Hill AL et al, 2012 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 28 14

  15. 10/8/2018 Transfusions in the OR MEAN MEDIAN RANGE pRBC (units) 22.2 (±10.3) 19 14-40 FFP (units) 17.6(± 15.3) 10 5-42 Platelets (units) 4 (± 3.5) 3 1-10 Cryoprecipitate 2.2 (± 1.3) 2 1-4 (10 pack unit) 1-3 x Estimated blood volume 29 How do they do? 7 Patients 15,727 Follow Up Days 2 patients > 10 Years (Up to12 Years) About 100 Endomyocardial Biopsies 30 15

  16. 10/8/2018 Where are they now? All are alive and well Normal Cardiac and Liver Function 3 Transitioned to adult programs But most impressively…. 31 Rejection Rates 100 Survival Rates # of Biopsies 1 year ‐ > 80% National (100% at LPCH) 10 year > 70% National (100% at LPCH) 0 0 1A 1B 2 3A 3B Rejection Grade 32 16

  17. 10/8/2018 Why do they do so well? More immunosuppression? More surveillance? More biopsies? 33 Why do they do so well? 34 17

  18. 10/8/2018 Immunologic Tolerance Liver protects companion organ in many combinations. Reduced rejection of both organs. Reduced incidence of coronary vascular disease Need for less immunosuppression. 35 Immunologic Tolerance 36 18

  19. 10/8/2018 37 UNOS Final Rule The goal of The organ allocation system in the US is to prioritize patients with the greatest medical urgency while at the same time maximizing the overall societal benefit from a limited pool of organs. Also takes into account the change in quality of life, duration of benefit, and amount of resources required for successful treatment. 38 19

  20. 10/8/2018 Our obligation as stewards… To prioritize patients with the greatest medical urgency … jumping the line for the 2 nd organ? …at the same time maximizing the overall societal benefit from a limited pool of organs. … saving one life instead of 2? Also takes into account the change in quality of life, duration of benefit, and amount of resources required for successful treatment. 39 Commitment to Patient vs. Society Individual Greater Good Patient Advocacy 40 20

  21. 10/8/2018 Justice Utility 41 Conclusions Heart ‐ Liver Transplant is increasing in frequency in adults and children Adolescents and adults with congenital heart disease make up a significant proportion of heart ‐ liver transplant candidates Indications are unclear Heavy surgical burden but patients survive Long ‐ term prognosis is excellent 42 21

  22. 10/8/2018 43 22

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend